ATLN
ATLN
NASDAQ · Life Sciences Tools & Services

Atlantic International Corp

$0.18
-0.01 (-6.37%)
As of Nov 17, 10:10 PM ET ·
Financial Highlights (FY 2026)
Revenue
3.29B
Net Income
-447,960,607
Gross Margin
10.5%
Profit Margin
-13.6%
Rev Growth
+1,669.6%
D/E Ratio
2.45
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 10.5% 42.5% 42.5% 42.5%
Operating Margin -11.5% 16.4% 14.8% 16.8%
Profit Margin -13.6% 9.8% 11.0% 12.8%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 3.29B 137.50M 128.72M 150.34M
Gross Profit 346.61M 58.38M 54.65M 63.83M
Operating Income -378,479,982 22.55M 19.09M 25.30M
Net Income -447,960,607 13.41M 14.17M 19.27M
Gross Margin 10.5% 42.5% 42.5% 42.5%
Operating Margin -11.5% 16.4% 14.8% 16.8%
Profit Margin -13.6% 9.8% 11.0% 12.8%
Rev Growth +1,669.6% +9.2% +17.5% -9.6%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 25.97M 64.08M 61.68M 71.70M
Total Equity 10.62M 174.87M 149.24M 163.17M
D/E Ratio 2.45 0.37 0.41 0.44
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -341,468,680 31.52M 29.06M 36.12M
Free Cash Flow — 19.05M 20.50M 15.74M